This Stock Could Be the Tesla of Healthcare – Motley Fool
|
This Stock Could Be the Tesla of Healthcare
Motley Fool The company has licensed exclusive rights to patents for the use of CRISPR-Cas9 in editing eukaryotic cells (i.e., any cells with a nucleus, including all human and animal cells). Editas also licensed patents to another type of gene editing, CRISPR … |
